The global digital therapeutics market is projected to reach USD 13.1 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 31.4% during the forecast period Growth in this market is primarily driven by the increasing incidence of preventable chronic diseases, the need to control healthcare costs, rising focus on preventive healthcare, and rising investments in digital therapeutics.
To know about the assumptions considered for the study @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724
Browse in-depth TOC on "Digital Therapeutics (DTx) Market"
157 – Tables
27 – Figures
204 – Pages
The B2B segment is the largest and fastest-growing segment of the market during the forecast period.
Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). In 2020, the B2B segment accounted for the largest share of 86.3% of the digital therapeutics market. This is attributed to growing awareness among providers, payers, and employers about the benefits of digital therapeutics and the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products.
Key Market Players
The digital therapeutics market is a highly diversified and competitive market, with several emerging players. The prominent players in this market include Noom (US), Livongo Health (US), Omada Health (US), WellDoc (US), Pear Therapeutics (US), Akili Interactive Labs (US), Better Therapeutics (US), Happify (US), Kaia Health (Germany), Mango Health (US), Click Therapeutics (US), Canary Health (US), Wellthy Therapeutics (India), Cognoa (US), Ayogo Health (Canada), CogniFit (US), Mindstrong Health (US), 2Morrow (US), and Ginger (US). The players in the market focus on providing effective products to cater to the unmet needs of customers, increase profitability, and gain a competitive edge in the market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724
Noom (US)
Noom (US) is one of the leading providers of the digital therapeutics market. The company provides best-in-class solutions for weight management, hypertension prevention, hypertension management, diabetes prevention, diabetes management, and comorbidities of hypertension and diabetes. The company adopts organic as well as inorganic strategies to strengthen its position in the digital therapeutics market. The company is supported by a number of investments, which have helped it bring digital therapeutic solutions to the market.
Omada (US)
Omada is one of the leading players in the digital therapeutics market. The company is engaged in designing and developing innovative digital therapeutic programs for preventable chronic diseases, including type 2 diabetes and heart disease. The company sells its products to major organizations, integrated delivery networks, and health plans.
Livongo Health (US)
Livongo Health (US) is one of the prominent players in the digital therapeutics market. The company focuses mainly on digital solutions for the management of chronic diseases. The company’s diabetes management solution has helped in reducing medical spending. Iron Mountain Incorporated (US) and Dean Foods (US), among others, have shared the positive impacts of Livongo’s diabetes management program. The merger between Teladoc and Livongo is one of the most significant integrations of competencies and skills in digital health.
North America commanded the largest share of the digital therapeutics market.
North America held the largest share of the DTx Market, followed by Europe. The market in North America is also expected to grow at the highest CAGR of 32.2%.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
